EHC - NYSE
Encompass Health Corporation
$103.17
+1.4%Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
At a Glance
Live SnapshotEncompass Health Corporation Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Healthy operating margins demonstrate effective cost control and strong business fundamentals.
Net Profit Margin
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Encompass Health Corporation Income Statement
EHC • NYSE
| Encompass Health Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
5.9B | 5.4B | 4.8B | 4.3B | 4B | 3.6B | 4.6B | 4.3B | 3.9B | 3.6B | 3.1B | 2.4B | 2.2B | 2.1B | 2B | 1.9B | 1.9B | 1.8B | 1.7B | 1.7B | |
GROSS PROFIT | ||||||||||||||||||||
(254.4M) | (3.1B) | (2.8B) | (2.6B) | (2.3B) | (171M) | (167.9M) | (158.7M) | (149.3M) | (140M) | (128.7M) | (111.9M) | (105.4M) | (102.4M) | (102.8M) | (99.4M) | (0.0) | (48.8M) | (100.3M) | (925.3M) | |
5.7B | 2.2B | 2B | 1.8B | 1.7B | 3.4B | 4.4B | 4.1B | 3.8B | 3.5B | 3B | 2.3B | 2.1B | 2B | 1.9B | 1.8B | 1.9B | 1.8B | 1.6B | 786.3M | |
OPERATING INCOME | ||||||||||||||||||||
(4.6B) | (1.4B) | (258M) | (1.1B) | (1B) | (3.4B) | (4.4B) | (4.1B) | (3.8B) | (3.5B) | (3B) | (2.3B) | (2.1B) | (2B) | (1.9B) | (1.8B) | (1.9B) | (1.8B) | (1.6B) | (786.3M) | |
(3.4B) | (266.5M) | (258M) | (209M) | (228.5M) | (2.1B) | (2.9B) | (2.7B) | (2.4B) | (2.2B) | (1.9B) | (1.3B) | (1.3B) | (1.2B) | (1.2B) | (1.1B) | (1.3B) | (1.1B) | (1.4B) | (631.5M) | |
1.1B | 864.5M | 1.7B | 630.2M | 659.4M | 0.0 | 692.5M | 681.6M | 649.4M | 648.8M | 554.2M | 465.7M | 458.8M | 413.4M | 374.1M | 327.8M | 276.9M | 406.6M | 188.1M | 68M | |
PRE-TAX INCOME | ||||||||||||||||||||
(123.2M) | (137.4M) | (143.5M) | (175.7M) | (164.3M) | (183.7M) | (159.7M) | (147.3M) | (154.4M) | (172.1M) | (142.9M) | (109.2M) | (100.4M) | (94.1M) | (119.4M) | (125.6M) | (125.8M) | (159.5M) | (0.0) | (0.0) | |
-123.2M | -137.4M | -143.5M | -175.7M | -164.3M | -183.7M | -159.7M | -147.3M | -154.4M | -172.1M | -142.9M | -109.2M | -100.4M | -94.1M | -119.4M | -125.6M | -125.8M | -159.5M | 0.0 | 0.0 | |
(1.2B) | (1.1B) | (0.0) | (914M) | (815.5M) | (1.3B) | (1.5B) | (1.5B) | (1.4B) | (1.3B) | (1.1B) | (925M) | (876.5M) | (799.7M) | (741.2M) | (671.8M) | (652.3M) | (661.6M) | (264.3M) | (154.8M) | |
-100.1M | -114.9M | -1.1B | -179.4M | -154.4M | 352.9M | -130.2M | -188.4M | -153M | -166.8M | -158.6M | -78.8M | -63.6M | -73.4M | -131.2M | -137.9M | -153.4M | -211.1M | -312.2M | -582.6M | |
953M | 749.6M | 607.2M | 450.8M | 505M | 352.9M | 562.3M | 493.2M | 496.4M | 482M | 395.6M | 386.9M | 395.2M | 340M | 242.9M | 189.9M | 123.5M | 195.5M | -124.1M | -514.6M | |
NET INCOME | ||||||||||||||||||||
(192.9M) | (150.2M) | (132.2M) | (100.1M) | (101.9M) | (74.7M) | (115.9M) | (118.9M) | (145.8M) | (163.9M) | (141.9M) | (110.7M) | (12.7M) | (108.6M) | (37.1M) | -740.8M | -3.2M | -70.1M | -322.4M | (22.4M) | |
566.2M | 455.7M | 352M | 271M | 412.2M | 284.2M | 358.7M | 292.3M | 271.1M | 247.6M | 183.1M | 222M | 323.6M | 185M | 208.7M | 899M | 94.8M | 252.4M | 653.4M | -625M |
SEC Filings
EHC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 01, 2026 | May 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 15, 2026 | May 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 11, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 01, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 07, 2026 | May 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 09, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K/A 8-K/A 2026 (Amended) N/A | February 20, 2026 | February 19, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 |
Related Guides
Continue your EHC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.